INZY vs GAUZ Comparison

Inozyme Pharma Incclinical-stage rare disease biopharmaceutical company developing novel therapeutics for the treatment of diseases impacting the vasculature, soft tissue, and skeleton. The company is pursuing the development of therapeutics to address the underlying causes of these debilitating diseases. The company is focused on developing a novel therapy to treat the rare genetic diseases of ENPP1 and ABCC6 Deficiencies. The company product candidate, INZ-701, is a soluble, recombinant, genetically engineered, fusion protein that is designed to correct a defect in a pathway involving ENPP1 and ABCC6 Deficiencies.

Gauzy Ltd is a integrated light and vision control company, Its products include suspended particle device, or SPD, and liquid crystal, or LC, films for smart glass applications, as well as camera monitoring systems, or CMS, and other advanced driver assistance systems, or ADAS, solutions. It has three operating segments. Architecture and automotive segment focuses on sales that enable OEMs to incorporate the Company's technology in glass rooftops, side windows and windshields. Safety tech segment focuses on sales of advanced driver assistance systems for buses, coaches, recreational vehicles and specific vehicles. Aeronautics segment focuses on the sale of shading and cabin management systems in private and commercial aircraft and helicopters. Key revenue is generated from Aeronauctis.